Global Blood Therapeutics, Inc. — Form D
Global Blood Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-05. The offering totals $48.0M, of which $48.0M was reported sold. Industry: Other.
Offering
- Filed: 2015-01-05
- Form: D
- Accession: 0001629137-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $48.0M
- Amount sold: $48.0M
- Investors: 13
- Date of first sale: 2014-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-231431
Issuer
- Name: Global Blood Therapeutics, Inc.
- CIK: 0001629137
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-741-7700
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Charles W Homcy, M.D. | Director | South San Francisco, CA |
| Ted W Love | Director | Cranbury, NJ |
| Kevin W Starr | Director | South San Francisco, CA |
| Ted W Love | Executive Officer | Cranbury, NJ |
| John W Schembri | Executive Officer | South San Francisco, CA |
More